Added survival benefit of whole brain radiotherapy in brain metastatic non-small cell lung cancer: Development and external validation of an individual prediction model

BACKGROUND: The heterogeneous survival benefit of whole brain radiotherapy (WBRT) in brain metastatic non-small cell lung cancer (NSCLC) was prospectively evidenced in the Quality of Life after Treatment for Brain Metastases (QUARTZ) trial, resulting in inconsistent guideline recommendations and div...

Descripción completa

Detalles Bibliográficos
Autores principales: Trikhirhisthit, Kyrhatii, Setakornnukul, Jiraporn, Thephamongkhol, Kullathorn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796174/
https://www.ncbi.nlm.nih.gov/pubmed/36591469
http://dx.doi.org/10.3389/fonc.2022.911835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796174/
https://www.ncbi.nlm.nih.gov/pubmed/36591469
http://dx.doi.org/10.3389/fonc.2022.911835

Ejemplares similares